News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Mary Ann Liebert, Inc. Release: Cutting-Edge Cellular Therapies And Stem Cell Applications Highlight Fourth Annual Conference On Regenerative Medicine In Washington, D.C.

10/19/2005 5:10:47 PM

LARCHMONT, N.Y.--(BUSINESS WIRE)--Oct. 14, 2003--The very latest research and clinical applications of cellular therapies and stem cell transplantation will be the focus of four presentations by leading researchers at the Fourth Annual Conference on Regenerative Medicine. With an emphasis on "Rebuilding the Body, Restoring Function," the Conference is jointly sponsored by Genetic Engineering News, a publication of (, the University of South Florida College of Medicine, and the Regenerative Medicine and Stem Cell Biology Society, and is presented by BioConferences International. The complete program including summaries of the presentations can be viewed at

Professor Ian Wilmut of the Roslin Institute will chair the session entitled "Cellular Therapies--Repairing the Damaged and Worn Body" and will deliver a presentation on "Nuclear Transfer as a Source of Cells for Therapy: Two Methods for Producing Immunologically Matched Cells." Approaches for overcoming the problem of immune rejection are the focus of two presentations: a talk by Roger Pedersen, Ph.D. from the Department of Surgery, University of Cambridge, Addenbrooke's Hospital on "Stem Cell Medicine Encounters the Immune System: Strategies for Avoiding Rejection"; and a discussion of "Purified Hematopoietic Stem Cells and the Induction of Immune Tolerance" by Judith A. Shizuru, M.D., Ph.D., Assistant Professor of Medicine at Stanford University School of Medicine. Taking an in-depth look at therapeutic applications of cellular therapies, Margaret A. Goodell, Ph.D., Assistant Professor, Center for Cell & Gene Therapy at Baylor College of Medicine, will speak on "The Derivation and Value of Hematopoietic Side Population Cells."

World-class scientists from leading academic centers, industry, and government research institutions will also present their most recent findings from the laboratory and the clinic during conference sessions that will focus on Substitutive Medicine: Organ Replacement and Repair, Exploring New Frontiers in Alzheimer's Disease, and Tissue Engineering.

Robert Langer, Ph.D. (MIT), will present the Keynote Address, entitled "Novel Biomaterials." In the New Ventures Address, Linda Powers, Managing Director of Toucan Capital, will provide a detailed overview of the current economic environment and discuss the opportunities and obstacles for early-stage funding.

For more information about the Fourth Annual Conference on Regenerative Medicine, including registration, submitting a poster abstract, sponsorships, and exhibits, please contact, (800) 5-BIOCON, (914) 834-3100, ext. 608, fax (914) 834-3689.


Mary Ann Liebert, Inc., Larchmont Harriet Matysko, 914-834-3100, ext. 608 800-5-BIOCON fax: 914-834-3689

Source: Mary Ann Liebert, Inc.

Read at

comments powered by Disqus